Sources

9 Total Sources

Novartis Pelacarsen Fails 8,000-Patient Heart Trial, Jolting $5 Billion Lp(a) Drug Race

Left33%

Center33%

Right33%

Novartis Pelacarsen Fails Cardiovascular Trial, Impacts Lp(a) Drug Race

Medical Daily21h ago

Novartis Heart Drug Lowered a Genetic Risk Factor but Did Not Cut Heart Attacks or Strokes

brandiconimage.com13h ago

Novartis Shares Fall After Cholesterol Drug Fails Major Heart Study

briefs.co13h ago

Novartis Heart Drug Fails Late Trial

The Wall Street Journal13h ago

Novartis Stock Prices Fall After Cholesterol Drug Pelacarsen Fails Heart Study - WSJ

pharmaphorum13h ago

Novartis hit as Lp(a) drug fails cardio outcomes trial | pharmaphorum

MD Magazine13h ago

Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial | HCPLive

inflectionlabs.bio13h ago

Lp(a) Drug Development Pipeline: Global Landscape | Inflection Labs

Yahoo Finance21h ago

Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down